Review article · 2018 · Open access
Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis
European Archives of Psychiatry and Clinical Neuroscience, 268(7), 625–639 · Published 24 January 2018 · DOI 10.1007/s00406-018-0869-3
In brief
“Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis” is a 2018 review article by Marc Krause and 6 co-authors, published in European Archives of Psychiatry and Clinical Neuroscience. OpenAlex counts 282 citations as of 20 November 2026, which puts it in the top 2% of works published in 2018 by citations. It is open access: the full text is free to read at Bern Open Repository and Information System (University of Bern).
- Citations
- 282
- Most cited in
- 2024 (53)
- Field-weighted impact
- 2.57
- References
- 66
- Authors
- 7
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Krause, M., Zhu, Y., Huhn, M., Schneider‐Thoma, J., Bighelli, I., Nikolakopoulou, A., & Leucht, S. (2018). Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis. European Archives of Psychiatry and Clinical Neuroscience, 268(7), 625–639. https://doi.org/10.1007/s00406-018-0869-3
MLA 9
Krause, Marc, et al. “Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis.” European Archives of Psychiatry and Clinical Neuroscience, vol. 268, no. 7, 2018, pp. 625–639. https://doi.org/10.1007/s00406-018-0869-3.
Chicago
Krause, Marc, Yikang Zhu, Maximilian Huhn, Johannes Schneider‐Thoma, Irene Bighelli, Adriani Nikolakopoulou, and Stefan Leucht. 2018. “Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis.” European Archives of Psychiatry and Clinical Neuroscience 268 (7): 625–639. https://doi.org/10.1007/s00406-018-0869-3.
Harvard
Krause, M. et al. (2018) ‘Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis’, European Archives of Psychiatry and Clinical Neuroscience, 268(7), pp. 625–639. doi:10.1007/s00406-018-0869-3.
IEEE
M. Krause et al., “Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis,” European Archives of Psychiatry and Clinical Neuroscience, vol. 268, no. 7, pp. 625–639, 2018, doi: 10.1007/s00406-018-0869-3.
BibTeX
@article{krause2018antipsychotic,
title = {{Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis}},
author = {Krause, Marc and Zhu, Yikang and Huhn, Maximilian and Schneider‐Thoma, Johannes and Bighelli, Irene and Nikolakopoulou, Adriani and Leucht, Stefan},
journal = {European Archives of Psychiatry and Clinical Neuroscience},
year = {2018},
volume = {268},
number = {7},
pages = {625--639},
doi = {10.1007/s00406-018-0869-3},
url = {https://doi.org/10.1007/s00406-018-0869-3}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2018 | 7 | |
| 2019 | 14 | |
| 2020 | 25 | |
| 2021 | 43 | |
| 2022 | 46 | |
| 2023 | 30 | |
| 2024 | 53 | |
| 2025 | 33 | |
| 2026 | 31 |
Its field-weighted citation impact is 2.57: it has been cited 2.57 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- schizophrenia
- negative symptoms
- antipsychotic drugs
- amisulpride
- olanzapine
- cariprazine
- risperidone
- quetiapine
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Krause, M., Zhu, Y., Huhn, M., Schneider‐Thoma, J., Bighelli, I., Nikolakopoulou, A., & Leucht, S. (2018). Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis. European Archives of Psychiatry and Clinical Neuroscience, 268(7), 625–639. https://doi.org/10.1007/s00406-018-0869-3
How many times has this paper been cited?
282 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Bern Open Repository and Information System (University of Bern): sign in and open the full text from this page.
Who wrote this paper?
Marc Krause, Yikang Zhu, Maximilian Huhn, Johannes Schneider‐Thoma, Irene Bighelli, Adriani Nikolakopoulou, Stefan Leucht.
What is the DOI of this paper?
10.1007/s00406-018-0869-3, permanently at https://doi.org/10.1007/s00406-018-0869-3. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.